Seller record · Telehealth service

Shapely

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The compounded medication pages refer only to reputable state-licensed 503A and 503B compounding pharmacies. 1 more criterion also fails; see the table below.

At a glance

ShapelyTelehealth service

6/8criteria passed

Price: Compounded semaglutide from $99 a month and tirzepatide from $166, plus a membership at $49 the first month on sale, regular $99
Sells: compounded semaglutide, compounded tirzepatide, Wegovy, and 6 more
FDA letters: None on file

Visit Shapely See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A physician-led obesity medicine practice that bills Medicare and PPO insurance for video visits with providers and dietitians and helps members get brand-name GLP-1s covered, in California, Florida, New York and Texas. It also sells compounded semaglutide and tirzepatide on a self-pay basis.

Operating entity Zaghi Medical, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Shapely's website; Shapely's about page
S2	Prescription gating	PASS	Shapely's website; Shapely's semaglutide page
S3	Pharmacy identification	FAIL	Shapely's semaglutide page; Shapely's tirzepatide page
S4	Compounding disclosure	PASS	Shapely's semaglutide page; Shapely's tirzepatide page; Shapely's website
S5	Analytical documentation	FAIL	Shapely's semaglutide page; Shapely's website; Shapely's terms of use page
S6	Business address	PASS	Shapely's privacy policy; Shapely's notice of privacy practices page; Shapely's terms of use page
S7	Price disclosure	PASS	Shapely's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEach member meets an assigned provider over video before any prescription, and prescriptions are at the provider's discretion. The about page names the founder, Dr. Justin Zaghi, board-certified in internal medicine and obesity medicine, and other physicians and physician assistants.Source: Shapely's website; Shapely's about page.

S2PASSThe steps are a two-minute check of insurance and health goals, then a video visit with a provider, then a treatment plan and prescriptions if appropriate. No medication is sold before the video visit.Source: Shapely's website; Shapely's semaglutide page.

S3FAILNo filling pharmacy is named. The compounded medication pages refer only to reputable state-licensed 503A and 503B compounding pharmacies.Source: Shapely's semaglutide page; Shapely's tirzepatide page.

S4PASSThe compounded semaglutide and tirzepatide pages and the answers state that compounded medications are not FDA-approved.Source: Shapely's semaglutide page; Shapely's tirzepatide page; Shapely's website.

S5FAILNo certificate of analysis or lot document is published on the medication pages, the answers or the terms.Source: Shapely's semaglutide page; Shapely's website; Shapely's terms of use page.

S6PASSZaghi Medical, Inc., doing business as Shapely, at 5665 W. Wilshire Blvd #1609, Los Angeles, CA 90036, printed in the privacy policy, the notice of privacy practices and the terms. The terms name Delaware law.Source: Shapely's privacy policy; Shapely's notice of privacy practices page; Shapely's terms of use page.

S7PASSThe self-pay membership costs $49 for the first month on sale, regular $99 a month, and covers visits and prescriptions but not medications or labs; insured members pay their plan's co-pays. Compounded semaglutide costs from $99 a month and compounded tirzepatide from $166 a month, self-pay. Labs cost $75 without insurance.Source: Shapely's website.

S8PASSNo FDA warning letter names Shapely or Zaghi Medical, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, Wegovy, Wegovy pill, Ozempic, Zepbound, Mounjaro, Foundayo, Contrave.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Shapely

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.